Company: HURA
Filing Date: 2025-08-12
Form Type: S-1
Source: 0001193125-25-179009
Chunk: 334

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-08-12
Form: S-1
Chunk 334
---
 | % |     |   |  91.9%—99.7 | % |

Below is a summary of stock option activity for the year ending December 31, 2024:

|                                                  |     | Number ofoptions |           |   |     | WeightedAverageExercise Price |          |     | WeightedAverageContractual Life |            |
|:-------------------------------------------------|:----|:-----------------|----------:|:--|:----|:------------------------------|---------:|:----|:--------------------------------|:-----------|
| Outstanding at December 31, 2023                 |     |                  | 2,781,064 |   |     | $                             |     2.97 |     |                                 | 4.43 years |
| Options assumed from Kintara upon merger closing |     |                  |     6,345 |   |     | $                             | 1,074.40 |     |                                 | 6.91 years |
| Forfeited and cancelled                          |     |                  |  (249,961 | ) |     | $                             |     3.53 |     |                                 |            |
| Exercised                                        |     |                  |  (180,689 | ) |     | $                             |     2.66 |     |                                 |            |
| Granted                                          |     |                  | 4,047,059 |   |     | $                             |     4.76 |     |                                 |            |
| Outstanding at December 31, 2024                 |     |                  | 6,403,818 |   |     | $                             |     5.11 |     |                                 | 7.44 years |
| Exercisable at December 31, 2024                 |     |                  | 2,270,626 |   |     | $                             |     5.83 |     |                                 | 3.30 years |

Options outstanding had an intrinsic value of $ 5,494,000 and $ 1,964,000 as of December 31, 2024 and December 31, 2023, respectively. As of December 31, 2024, there was $ 14,300,000 of unrecognized stock compensation, which will be recognized over the next three years .

Restricted Stock units

Restricted stock units “RSU” were assumed from the merger issued to the former Chief Executive Officer and currently is a board of director for the Company and